Page 29 - Senza Omnia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article REDWOOD CITY, Calif., Jan. 27, 2021 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company will report its financial results for the fourth quarter and full-year ended December 31, 2020 after the market closes on February 24, 2021. Management will host a conference call on February 24, 2021 to discuss fourth quarter and full-year 2020 financial results. The call will begin at 1:30 pm PT/ 4:30 pm ET.  Investors i...

"Nevro is proud to continue our longstanding commitment to investing in the field of neuromodulation and expanding our growing body of clinical evidence," said D. Keith Grossman, Chairman, CEO and President of Nevro. "We are excited for Dr. Petersen and Dr. Kapural to share the significant data from the SENZA-PDN and the SENZA-NSRBP trials at NANS, reflecting our commitment to helping physicians treat underserved patient populations suffering from debilitating chronic pain. Additionally, we are pleased the many clinical investigators studying HF10 will have the opportunity to present the resu...

Nevro Announces FDA Submission for HF10® Therapy in Patients with Painful Diabetic Neuropathy SENZA-PDN Study is Largest Prospective, Multicenter, Randomized Clinical Trial of Spinal Cord Stimulation Conducted to Date News provided by Share this article REDWOOD CITY, Calif., Dec. 28, 2020 /PRNewswire/ --  Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the company has submitted a pre-market approval supplement to the U.S. Food and Drug Administration (FDA) to seek appro...

Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference Friday, January 15, 2021, at 4:00 pm Pacific Time / 6:00 pm Central Time News provided by Share this article Share this article REDWOOD CITY, Calif., Dec. 22, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced it will host and webcast a virtual investor briefing at the 2021 North American Neuromodulation Society (NANS) Virtual Conference on Friday...

Share this article Share this article REDWOOD CITY, Calif., Dec. 15, 2020 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, will present at the 39 th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021, at 4:30 pm Eastern Time / 1:30 pm Pacific Time. A live webcast of this event, as well as an archived recording, will be available in the Investors section of Nevro's website at www.nev...